Chronic illness drug developer Sigilon Therapeutics, co-founded by MIT and UIC researchers, has filed to go public after raising almost $200m in funding.

The University of Cambridge-aligned healthcare and life sciences accelerator has added Novartis as a strategic partner.

Existing backers Takeda, Deerfield and Bay City Capital have provided $10m to help progress research from multiple institutions.

Gene editing technology developer Metagenomi advances research from UC Berkeley and has raised a series A co-led by Bayer.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Co-founded by a team of doctors and computer scientists out of Harvard Innovation Labs, Buoy Health has grown its overall financing to $66.5m.

Boston Children’s Hospital is the 18th university or research institute to receive academic bridge funding from Deerfield Management.

Partly based on University of Bern research, Synendos aims to restore the endocannabinoid system to treat dysfunction in the central nervous system.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Neuros Medical, a Case Western Reserve University spinout, has raised $69.8m since it was founded in 2008.